William Blair analyst Adam Klauber has maintained their bullish stance on RYAN stock, giving a Buy rating on December 4.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Adam Klauber has given his Buy rating due to a combination of factors that highlight Ryan Specialty Group’s strong growth trajectory and strategic positioning in the market. The company has effectively capitalized on the increasing institutionalization of the delegated underwriting authority sector, positioning itself as a leading platform with substantial premiums and a diverse product range. This growth is evident in the significant increase in revenue contribution from its binding authority and underwriting management divisions, which have expanded through organic growth and strategic acquisitions.
Furthermore, recent partnerships, such as those with Nationwide reinsurance MGU and RAC Re sidecar, are expected to enhance capacity and business lines, reinforcing the company’s robust growth outlook. Despite potential risks related to carrier contracts and economic conditions, Klauber is optimistic about Ryan Specialty Group’s ability to maintain organic growth above 10% in the coming years. The stock’s valuation at approximately 22 times the projected 2026 P/E, coupled with its EPS compounding potential, supports the Buy recommendation.
Klauber covers the Financial sector, focusing on stocks such as Progressive, Ehealth, and Kinsale Capital Group. According to TipRanks, Klauber has an average return of 0.7% and a 44.12% success rate on recommended stocks.
In another report released on December 4, Citi also maintained a Buy rating on the stock with a $74.00 price target.